OmniSpirant Limited Appoints Andy Fisher to its Board of Directors

Galway, Ireland 4th May 2023 OmniSpirant is excited to announce the appointment of Andy Fisher to its board of directors. For nearly 20 years, Andy held leadership positions at United Therapeutics Corporation, a global biotechnology company focused on chronic and life-threatening conditions in areas of unmet medical need. Most recently, he was Chief Strategy Officer [...]

2023-05-04T16:27:28+01:00May 4th, 2023|

Emily’s Entourage Grants $220k to Queen’s University Belfast to advance OmniSpirant’s Gene Therapy for Cystic Fibrosis

PRESS RELEASE We are excited to progress the development of OS001 for CF in collaboration with Prof Lorraine Martin and Dr Lisa Douglas in Queen's University Belfast. Funding support from Emily's Entourage in the USA and The CF Trust in the UK is matched by their scientific expertise which will help to shape further exciting [...]

2023-03-26T21:52:30+01:00January 20th, 2023|

OmniSpirant Limited Announces the Launch of INSPIRE; an EU Project funded under the Horizon Europe research and innovation programme to develop a ground-breaking inhaled gene therapy for the treatment of lung cancer.

PRESS RELEASE OmniSpirant Limited are delighted and honoured to announce the launch of INSPIRE, a €12.8 million lung cancer project funded by Horizon Europe. In one of the largest ever grants for preclinical research in lung cancer, OmniSpirant in collaboration with our European partners spanning across biotechnology, medical devices, cancer research, academia and patient advocacy, [...]

2023-03-07T23:28:42+00:00December 14th, 2022|

OmniSpirant Named in the World’s Top 5 Startups Developing Drugs for Respiratory Disease

StartUs insights analysis of the global respiratory drug development landscape highlights OmniSpirant's inhaled regenerative gene therapy platform: Omnispirant explores Inhaled Gene Therapy In the last decade, advances in gene sequencing and gene editing have made gene therapy more feasible than ever before. For the treatment of respiratory diseases, gene therapy offers a way to correct [...]

2023-03-07T23:27:00+00:00March 11th, 2021|

Irish Consortium to Develop Novel Treatment for ARDS and COPD

Pictured from left to right: Dr Janusz Krawczyk, Dr Róisín Dwyer, Prof John Laffey, Dr Ronan MacLoughlin, Gerry McCauley, Dr Daniel O’Toole and Dr Katie Gilligan ​ NUI Galway, OmniSpirant Limited and Aerogen Limited have been awarded major funding to develop a new aerosol treatment that will transform respiratory medicine, with potential benefits across acute [...]

2023-03-07T23:21:49+00:00September 30th, 2020|
Go to Top